Download video

Trina L. Abla, DO, MBA, Chief Medical Officer (CMO) | Why Penn Highlands Healthcare

83 views

Penn Highlands Healthcare

8 months ago

Trina L. Abla, DO, MBA, Chief Medical Officer (CMO) | Why Penn Highlands Healthcare

Trina L. Abla, DO, MBA, Chief Medical Officer (CMO) | Why Penn Highlands Healthcare

Phase II trial of neoadjuvant durvalumab \& chemotherapy in high-risk UTUC
2:19
Phase II trial of neoadjuvant durvalumab \& chemotherapy in high-risk UTUC
by VJOncology
Touch Tuina medical treatment for back pain
7:52
Touch Tuina medical treatment for back pain
by ErrolLynch
The OncoAlert Weekly Round Up Sept 25-Oct 2, 2025 : DESTINY Breast05 \/ NATALEE \/ PROGRESS
4:09
The OncoAlert Weekly Round Up Sept 25-Oct 2, 2025 : DESTINY Breast05 \/ NATALEE \/ PROGRESS
by OncoAlert 360
The OncoAlert Weekly Round Up October 3 to 9, 2025. TROPION-Breast02 , IMforte
4:44
The OncoAlert Weekly Round Up October 3 to 9, 2025. TROPION-Breast02 , IMforte
by OncoAlert 360
A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML
4:27
A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
062 MNL Breast Cancer Pt 2
48:42
062 MNL Breast Cancer Pt 2
by Dr. Natalie Nash
Limitations and potential of Phase II PATRICIA trial in HER2+\/HR+ advanced breast cancer
0:48
Limitations and potential of Phase II PATRICIA trial in HER2+\/HR+ advanced breast cancer
by VJOncology
Trastuzumab Deruxtecan FDA Approval and Future Directions for HER2-Positive Bladder Cancer
14:21
Trastuzumab Deruxtecan FDA Approval and Future Directions for HER2-Positive Bladder Cancer
by GU Oncology Now
7 BIG EFFECTS of Trazodone!
7:37
7 BIG EFFECTS of Trazodone!
by Behind Medicine
Cretostimogene for High-Risk NMIBC: CORE-008, BOND-003, and PIVOT-006
5:50
Cretostimogene for High-Risk NMIBC: CORE-008, BOND-003, and PIVOT-006
by GU Oncology Now
Stories of Hope: Facing Breast Cancer (Full Show)
23:04
Stories of Hope: Facing Breast Cancer (Full Show)
by WGN News
PATRICIA: Phase II study of palbociclib, trastuzumab, and endocrine therapy in HER2+ advanced BC
0:44
PATRICIA: Phase II study of palbociclib, trastuzumab, and endocrine therapy in HER2+ advanced BC
by VJOncology
Navigating Breast Cancer Care | Part 2: Treatment
57:32
Navigating Breast Cancer Care | Part 2: Treatment
by NYU Langone Health
FDA Approves Inluriyo: New Hope for ER+, HER2-, ESR1-Mutated Advanced Breast Cancer
2:46
FDA Approves Inluriyo: New Hope for ER+, HER2-, ESR1-Mutated Advanced Breast Cancer
by 洋佳酱 YangJia
Tina Bhutani, MD - CBC before ruxolitinib in patients with thrombocytopenia, anemia, or neutropenia?
0:23
Tina Bhutani, MD - CBC before ruxolitinib in patients with thrombocytopenia, anemia, or neutropenia?
by Dermsquared